joseph ciccolini
  • E-mail :[email]
  • Phone : +33 4 91 83 55 09
  • Location : Marseille, France
Last update 2015-11-01 18:04:03.841

joseph ciccolini Pharm.D., Ph.D. in Pharmacokinetics

Course and current status

• Current Position:

Assistant Professor in Pharmacokinetics, School of Pharmacy of Marseille, Aix-Marseille Univ (AMU) Marseille France;

Group Leader at the SMARTc unit, Inserm UMR S_911 CRO2, Aix-Marseille Univ (AMU), Marseille France;

Clinical Pharmacologist, University Hospital of Marseille (APHM), Marseille France.

 

 • Education:

2006: HDR (a.k.a. Tenure)

1997-2000: PH.D. in Pharmacokinetics, AMU France.

1995-1996: Merck Pharmaceuticals, R&D Facility, Hitchin Hertfordshire. UK.

1994: Pharm.D., AMU France.

Scientific summary

• Group Leader of the Experimental PK group of the SMARTc Unit (UMR S_911, CRO2 AMU France).

• Main area of research: controling the pharmacokinetics variability of anticancer agents (i.e., cytotoxics, targeted therapies, biologics) and implementing precision medicine in oncology.

This includes (non clinical + clinical applications):

- developing novel drug delivery systems.

- developing therapeutic drug monitoring strategies.

- developing adaptive dosing strategies.

- developing new computer-aided regimen.

- developing and implementing pharmacogenetic-testing at bedside.

 

• Patents:

- 2010: Liposomal formulations for treating cancer (UC ˛0100166848).
 
- 2013: Method for assessing the ability of a patient to be safely treated by a nucleoside analog-based chemotherapy (US20130011392A1).

- 2015: Immunoliposomes Formulation (EP15305595.9)

• Head of the Master Degree in Pharmacokinetics (AMU).

 

• Expert at: INCa, ANR, ANRT, SATT, ANSM, CR-UK.

 

• Societies: AACR, PAMM-EORTC, GMP, GPCO-Unicancer, ESPT, ASCO.

 

• Publications list:

88 international papers in the field of anticancer drugs pharmacokinetics and pharmacogenetics.

Full list at: http://www.ncbi.nlm.nih.gov/pubmed?term=Ciccolini%20J[Author]

Image d’exemple